Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity.

Honghong Yao,Fuwang Peng,Navneet Dhillon,Shannon Callen,Sirosh Bokhari,Lisa Stehno-Bittel,S Omar Ahmad,John Q Wang,Shilpa Buch

DOI: https://doi.org/10.1523/JNEUROSCI.2781-08.2009

2009-01-01

Journal of Neuroscience

Abstract:Chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte chemoattractant protein-1, plays a critical role in leukocyte recruitment and activation. In the present study, we identify an additional role for CCL2 that of neuroprotection against HIV-1 transactivator protein ( Tat) toxicity in rat primary midbrain neurons. Furthermore, we report the involvement of transient receptor potential canonical ( TRPC) channels in CCL2-mediated neuroprotection. TRPC are Ca2+-permeable, nonselective cation channels with a variety of physiological functions. Blockage of TRPC channels resulted in suppression of both CCL2-mediated neuroprotection and intracellular Ca2+ elevations. Parallel but distinct extracellular signal-regulated kinase (ERK)/cAMP response element-binding protein ( CREB) and Akt/nuclear factor kappa B (NF-kappa B) pathways were involved in the CCL2-mediated neuroprotection. Blocking TRPC channels and specific downregulation of TRPC channels 1 and 5 resulted in suppression of CCL2-induced ERK/CREB activation but not Akt/NF-kappa B activation. In vivo relevance of these findings was further corroborated in wild-type and CCR2 knock-out mice. In the wild-type but not CCR2 knock-out mice, exogenous CCL2 exerted neuroprotection against intrastriatal injection of HIV-1 Tat. These findings clearly demonstrate a novel role of TRPC channels in the protection of neurons against Tat through the CCL2/CCR2 axis.